Protagonist Therapeutics Inc (PTGX:NASDAQ)

$87.1 -0.29 (-0.33%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 62

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Protagonist Therapeutics Inc (PTGX:NASDAQ) News Sources

Protagonist Therapeutics: Q4 Earnings Snapshot

Yahoo Finance

Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit

Yahoo Finance

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in March 2026

The Palm Beach Post

Protagonist Therapeutics: CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

FinanzNachrichten.de

Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

USA TODAY

Protagonist Therapeutics: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

FinanzNachrichten.de

CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

USA TODAY

Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (BIIB), Guardant Health (GH) and PTC Therapeutics (PTCT)

The Globe and Mail

Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and PROCEPT BioRobotics (PRCT)

The Globe and Mail

North American Morning Briefing: Markets Fall, Oil Surges on U.S.-Iran Fears -2-

Morningstar

PTGX stock
PTGX stock price
PTGX stock price today
PTGX stock prediction
PTGX earnings date
PTGX news
PTGX price
PTGX share
PTGX share price
PTGX shares
PTGX ceo
PTGX premarket
$PTGX
PTGX ticker
PTGX after hours
PTGX stock
PTGX stock price
PTGX stock price today
PTGX stock prediction
PTGX earnings date
PTGX news
PTGX price
PTGX share
PTGX share price
PTGX shares
PTGX ceo
PTGX premarket
$PTGX
PTGX ticker
PTGX after hours

Protagonist Therapeutics Inc (PTGX:NASDAQ) FAQs

toggle

What is the current price of Protagonist Therapeutics Inc (PTGX:NASDAQ)?

The current price of Protagonist Therapeutics Inc (PTGX:NASDAQ) is $87.1.


toggle

Protagonist Therapeutics Inc (PTGX:NASDAQ) absolute price change since previous trading day?

The absolute price change of Protagonist Therapeutics Inc (PTGX:NASDAQ) since the previous trading day is $-0.29.


toggle

Protagonist Therapeutics Inc (PTGX:NASDAQ) percentage price change since previous trading day?

The percentage price change of Protagonist Therapeutics Inc (PTGX:NASDAQ) since the previous trading day is -0.33%.


toggle

What is This Week's average sentiment score for Protagonist Therapeutics Inc (PTGX:NASDAQ)?

This Week's average sentiment score for Protagonist Therapeutics Inc (PTGX:NASDAQ) is 62 out of 100.


toggle

What is This Week's average sentiment for Protagonist Therapeutics Inc (PTGX:NASDAQ)?

This Week's sentiment for Protagonist Therapeutics Inc (PTGX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.